Share Name Share Symbol Market Type Share ISIN Share Description
Smiths Group LSE:SMIN London Ordinary Share GB00B1WY2338 ORD 37.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.00p -0.23% 1,295.00p 1,292.00p 1,293.00p 1,304.00p 1,287.50p 1,303.00p 1,494,907 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Industrials 3,213.0 435.0 70.0 18.5 5,128.49

Smiths Group Share Discussion Threads

Showing 1001 to 1024 of 1025 messages
Chat Pages: 41  40  39  38  37  36  35  34  33  32  31  30  Older
DateSubjectAuthorDiscuss
08/8/2018
07:47
Smiths Group, the FTSE-100 in‎dustrial conglomerate, is close to calling off talks with a rival about a £7bn merger that would have created a transatlantic healthcare giant. Sky News has learnt that Smiths is leaning towards a decision to halt negotiations with Nasdaq-listed ICU Medical about a tie-up more than two months after they got underway. A final decision has yet to be made by Smiths' chief executive, Andy Reynolds Smith, and a person close to the British company insisted on Tuesday night that any change in its position would be announced immediately to the London Stock Exchange. Banking sources said that news of the talks between Smiths and ICU, which were confirmed after Sky News revealed them in May, had prompted Baxter International, another US healthcare company, to express an interest in buying Smiths Medical outright. It was unclear whether any live talks were still taking place between Smiths and Baxter or any other potential suitors. News of the discussions was welcomed by Smiths investors in May amid hopes that the company was close to unlocking part of the value bound up in its conglomerate structure. Since then, both Smiths and ICU are said to have tabled a string of proposals about how a combination could work, with varying degrees of governance and management control being held by the two parties. ICU, which makes devices used in infusion therapy and oncology, is thought to have been keen on a formal merger of the businesses rather than a more straightforward joint venture. The Nasdaq-listed ICU has a market value of $6bn‎ (£4.6bn), while Smiths Medical was likely to have been valued at more than £2.5bn (£1.9bn) in a transaction. The US-based company has a long track record of takeovers including the $900m purchase completed last year of Pfizer's Hospira Infusion Systems arm. Smiths Medical, which also supplies advanced devices to healthcare markets around the world, accounts for just under 30% of the group's revenues, making it the company's largest unit on that basis. Its performance has been rocky in recent years, with revenue in the half-year to January down 5% to £451m. Last month, Smiths Group shares tumbled after the company said that changes to European Union rules on medical devices would hurt sales from 2020. The company said this year that it was making "significant progress on its return to growth" in the medical‎ arena but cautioned that higher research and development costs were having an impact on short-term profitability. Smiths also operates in areas such as security detection, making much of the body-scanning equipment used at airports around the world. In total, it has five main divisions‎, which also include John Crane, a provider of engineering solutions for energy and other process industries. The company's structure has long been a source of consternation for some investors and analysts, although talk of a takeover or break-up has never resulted in significant corporate activity. In recent months there has been growing talk among City investors that Smiths is likely to attract the attention of an activist investor keen on pressing more aggressively for a break-up, although its shares have generally performed strongly in recent months and are up modestly over the last year. Such activism has become increasingly common in the UK‎, with companies including FirstGroup, the transport operator, drug-maker Shire and Costa Coffee-owner Whitbread all the subject of current campaigns. Mr Reynolds Smith, who joined the company in 2015 from GKN, the engineering firm which has just been bought by Melrose Industries, is under pressure to demonstrate that its existing structure continues to deliver benefits to shareholders.
broadwood
28/5/2018
11:17
Article in The Times today - "early stage", "joint venture" etc Smiths Group in talks over healthcare ‘merger’ with US rival ICU Medical //www.thetimes.co.uk/edition/business/smiths-group-in-talks-over-healthcare-merger-with-us-rival-icu-medical-zrznxsvq3
sandlab
02/5/2018
16:19
Getting a nice little run going.
broadwood
30/4/2018
07:38
Smiths Group was a 'hold' for the Sunday Times' Inside the City column as chief executive Andy Reynolds Smith puts his shirt on full-year results from the engineering conglomerate in the autumn. The group is divided into five divisions: Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. John Crane makes mechanical seals, couplings and filtration systems; Smiths Medical specialises in catheters, needles, systems for managing airway and temperature and emergency patient transport; Detection's products are sensors and systems for airports; Interconnect's are electronic connections, including cables and wireless; while Flex-Tek provides components to heat and move fluids and gases for the aerospace, medical, industrial, construction and domestic appliance markets. The first two contribute more than a quarter of groups revenues each, detection just under a quarter and the latter two around 10% apiece. Reynolds Smith was appointed with a growth remit and has been acquisitive in since joining in September 2015. The following year the shares surged 50%, but until the start of April had nothing to show. Interim results in March knocked disappointed the market as profit fell and missed analysts' forecasts. “The time is coming when he will be judged by the measurable impact of his actions — including the purchase of Morpho — rather than presentations,”; Investec said. In order to meet the CEO's full year targets, revenues need to jump after slipping 1% in the first half at constant currency levels.
broadwood
28/3/2018
08:15
Q&A from the recent conference call are well worth a listen. Was not surprised to see the share price recover somewhat on Friday.
mertles
26/3/2018
08:41
Rather silent in here - good upwards movement over next few weeks IMO
ernestsyngen
12/1/2018
08:31
Another neglected thread. Positive comment this morning on US tax implications.
broadwood
18/8/2017
16:56
Industrial technology firm Smiths Group has spent most of the past year offloading different businesses but the rumour doing the rounds in the City today was it could soon change tack. On a quiet Friday, the hearsay was that the FTSE 100 company has its eye on Accelerate Diagnostics, a little-known US medical technology firm worth $1.3 billion (£1 billion) on Nasdaq. The Arizona-based company is working towards commercialising technology which helps to diagnose infectious diseases sooner. Its shares rose 5% yesterday against a falling market with trading volumes much higher than normal. Although Smiths’ name is in the frame for a potential tilt, larger US groups have a head-start on it, sources said. Frontrunners for Accelerate are said to be Thermo Fisher Scientific and Boston Scientific — both are much larger and have far more firepower than Smiths, whose operations range from energy services to specialist medical devices. It has sold several non-core business over the past year to buoy the balance sheet. After recent falls, Accelerate’s shares are now changing hands for only $23 a pop. Gossips said Accelerate and its directors, who control a large chunk of the company, would hold out for at least $35 a share. Smiths and Accelerate said they do not comment on speculation. Shares in Smiths were down 10.15p to 1553p, tracking UK stocks lower as investors digested the Barcelona terror attack and the increasingly chaotic nature of Donald Trump’s presidency. London Ev Standard HTTPS://www.standard.co.uk/business/market-report-city-chatter-says-smiths-is-mulling-bid-for-us-firm-accelerate-diagnostics-a3614931.html
philanderer
01/8/2017
11:18
SMIN 1,553 is starting to look like the only way is up in near future.
corlis
22/5/2017
14:50
Poached and on gardening leave or blackhole?
linhur
19/5/2017
12:18
Out on todays news.
philanderer
18/5/2017
10:51
Airline association IATA has called on the European Commission and the US government to adopt additional airport safety measures rather than expand the current, controversial ban on personal electronic devices (PEDs) in the cabin of flights from Middle Eastern and North African countries. HTTPS://www.flightglobal.com/news/articles/iata-warns-eu-and-us-authorities-on-electronics-ban-437316/
philanderer
17/5/2017
01:01
SMIN Smiths Group plc Smiths Detection Wins London Gatwick Airport Contract for CTX 9800 Hold Baggage Explosives Detection Systems CAMBRIDGE, England--(BUSINESS WIRE)-- - See more at: HTTPS://www.researchpool.com/company/smin-gb00b1wy2338-smiths-group-plc/press/smiths-group-plc-smin-smiths-detection-wins-london-gatwick-airport-contract-for-ctx-9800-hol#sthash.d7NmgUqB.dpuf
philanderer
03/5/2017
17:36
3rd may Deutsche buy tp 1750p 3rd may JP Morgan overweight tp 1730p reiterations
philanderer
02/5/2017
10:00
Streamlining continues , Microwave Telecoms booted.
philanderer
28/4/2017
21:19
Ah , thanks martin :-) Nice dividend paid into the account today as well.
philanderer
28/4/2017
13:51
Good find Phil. You were looking a bit lonely here, so I thought I would let you know that you are not alone!! I am very optimistic for #SMIN and we should see significant share price upside in the next 12 months IMO........I Hold.
martinthebrave
28/4/2017
13:22
2 Top FTSE 100 stocks for explosive earnings growth HTTP://www.aol.co.uk/money/2017/04/28/2-top-ftse-100-stocks-for-explosive-earnings-growth/
philanderer
10/4/2017
16:27
Goldman raises tp from 1800p to 1850p ... Buy
philanderer
08/4/2017
07:24
Smiths Group announces completion of acquisition of Morpho Detection HTTP://www.smithsdetection.com/index.php?option=com_k2&view=item&id=598:smiths-group-announces-completion-of-acquisition-of-morpho-detection&lang=es#.WOiBla9HmrU
philanderer
06/4/2017
09:58
6th april HSBC buy tp 1900p up from 1700p
philanderer
05/4/2017
09:06
xd tomorrow morning for the 13.55p dividend
philanderer
02/4/2017
09:54
Smiths Group: Market Is Undervaluing Improvements Even At 52-Week Highs HTTPS://seekingalpha.com/article/4059452-smiths-group-market-undervaluing-improvements-even-52-week-highs
philanderer
30/3/2017
14:32
30th march RBC outperform tp 1750p up from 1700p
philanderer
Chat Pages: 41  40  39  38  37  36  35  34  33  32  31  30  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20181020 08:58:25